rapiscan
ge healthcare as - regadenoson - myokardiell perfusion imaging - hjärtbehandling - detta läkemedel är endast för diagnostisk användning. rapiscan är en selektiv koronar vasodilaterande för att användas som en farmakologisk stress agent för radionuklid " myocardial perfusion imaging (mpi) hos vuxna patienter som inte kan genomgå tillräcklig motion stress.
tallium (tl-201) klorid curiumpharma 37 mbq/ml injektionsvätska, lösning
curium netherlands b.v. - tallium(tl-201)klorid - injektionsvätska, lösning - 37 mbq/ml - tallium(tl-201)klorid 37 mbq aktiv substans - tallium(tl-201)klorid
rilonacept regeneron (previously arcalyst)
regeneron uk limited - rilonacept - cryopyrin-associerad periodiskt syndrom - immunsuppressiva - rilonacept regeneron är indicerat för behandling av kryopyrinassocierade periodiska syndrom (caps) med svåra symtom, inklusive familjär kall auto-inflammatoriska syndrom (familjärt fcas) och muckle-wells syndrom (mws), hos vuxna och barn 12 år och äldre.
libtayo
regeneron ireland designated activity company (dac) - cemiplimab - carcinom, squamous cell - antineoplastiska medel - cutaneous squamous cell carcinomalibtayo as monotherapy is indicated for the treatment of adult patients with metastatic or locally advanced cutaneous squamous cell carcinoma (mcscc or lacscc) who are not candidates for curative surgery or curative radiation. basal cell carcinomalibtayo as monotherapy is indicated for the treatment of adult patients with locally advanced or metastatic basal cell carcinoma (labcc or mbcc) who have progressed on or are intolerant to a hedgehog pathway inhibitor (hhi). non-small cell lung cancerlibtayo as monotherapy is indicated for the first-line treatment of adult patients with non-small cell lung cancer (nsclc) expressing pd-l1 (in ≥ 50% tumour cells), with no egfr, alk or ros1 aberrations, who have:locally advanced nsclc who are not candidates for definitive chemoradiation, ormetastatic nsclc. libtayo in combination with platinum‐based chemotherapy is indicated for the first‐line treatment of adult patients with nsclc expressing pd-l1 (in ≥ 1% of tumour cells), with no egfr, alk or ros1 aberrations, who have:locally advanced nsclc who are not candidates for definitive chemoradiation, ormetastatic nsclc. cervical cancerlibtayo as monotherapy is indicated for the treatment of adult patients with recurrent or metastatic cervical cancer and disease progression on or after platinum-based chemotherapy.
lutinus 100 mg vaginaltablett
ferring läkemedel ab - progesteron - vaginaltablett - 100 mg - laktosmonohydrat hjälpämne; progesteron 100 mg aktiv substans; natriumlaurilsulfat hjälpämne - progesteron
cyclogest 400 mg vagitorium
gedeon richter plc - progesteron - vagitorium - 400 mg - progesteron 400 mg aktiv substans
cyclogest 400 mg vagitorium
ebb medical ab - progesteron - vagitorium - 400 mg - progesteron 400 mg aktiv substans
cyclogest 400 mg vagitorium
orifarm ab - progesteron - vagitorium - 400 mg - progesteron 400 mg aktiv substans
gepretix 200 mg kapsel, mjuk
exeltis healthcare, s.l. - progesteron - kapsel, mjuk - 200 mg - progesteron 200 mg aktiv substans; glycerol hjälpämne; sojalecitin hjälpämne
gepretix 100 mg kapsel, mjuk
exeltis healthcare, s.l. - progesteron - kapsel, mjuk - 100 mg - sojalecitin hjälpämne; glycerol hjälpämne; progesteron 100 mg aktiv substans